Parkinson's Disease Clinical Trial
Official title:
A Pilot Study of the Effects of Balance Training Using the Wii Balance Board on Balance and Ambulation in Adults With Parkinson's Disease
The purpose of this study is to assess the facilitation of balance in Parkinson's disease (PD) patients using the Nintendo Wii fit, with the ultimate goal of developing a program for function and fitness in this patient population. In this study, PD patients will participate in group exercise classes using the Wii Fit and the effects on balance, postural sway, and quality of life assessed.
The study is a cohort study using outpatients with Parkinson's Disease in Hoen and Yahr
Stage 2.5 - 3. Participants will have pre- and post-exercise testing, as well as participate
in an 8-week balance-training program.
Subjects Subjects will be recruited from the outpatient clinics (physician, therapy) at the
Rehabilitation Institute of Chicago (RIC) as well as the Northwestern Movement Disorders
Clinic, through the Department of Neurology. Approximately 20 subjects will be screened for
inclusion from these institutions and 12 subjects will be enrolled in the study. (see Power
analysis below).
Recruitment Procedures
Potential subjects will be approached by their treating outpatient physician (Physiatrist or
Neurologist) or Physical or Occupational Therapist to see if they would be interested in
participating in the study. The principal investigator will also send introductory letters
to his outpatients at RIC informing them of the study. Letters will only be sent to the PI's
patients (Dr. Marciniak, Dr. Toledo). Potential subjects will be educated regarding study
procedures, risks and benefits, and privacy risks. Informed consent will be obtained only
during initial screening and signed if the patient is interested in proceeding. Eligibility
criteria will be screened for (See below). Subjects who lack decisional capacity will not
included in the study.
Study Procedures This study will involve an initial visit (Visit 1) for screening and
baseline data collection. The therapy/intervention sessions will be held 3 times per week
for 8 weeks, (Visits 2 - 25), and there will be 1 post-intervention visit for data
collection (Visit 26). Subjects will be reimbursed 11 dollars for parking expenses that will
be mailed to them weekly in the form of a check. All visits will take place at Abbott Hall,
3rd floor exercise room and all visits will take approximately 1 ½ hrs.
Visit 1
Following consent, the following baseline measures will be performed:
1. Physician screening with a medical history (including falls in the month prior to the
visit) and physical examination
2. Mini Mental Status Examination (MMSE)
3. Hoehn and Yahr Staging
4. Questionnaires:
1. Activities-Specific Balance Scale
2. Parkinson's Disease Quality of Life measure (PDQ-8 c. Geriatric Depression Scale.
5. Berg Balance Scale, performed by a trained physical therapist
6. Dynamic Gait Index, performed by the physical therapist
7. Gait and mobility subscales of the UPDRS
8. Sharpened Romberg with eyes open and closed
9. Balance will also be measured using the Wii balance board. Subjects will stand on the
board and a gait belt will be placed around their waist. Subjects will have an
accelerometer (done via smart phone) clipped to their waist to measure sway, they will
stand on the Wii board, and the subject's ability to performing a reaching task will be
assessed, as measured by postural sway.
The investigator will remain immediately next to the subject during the testing procedures
for safety purposes with the gait belt in place, and a balance bar will also be next to the
patient during the testing procedures.
Visits 2- 25 (3x/ week for 8 weeks) (Within 2 weeks of initial testing) The subjects will be
seen at the Wirtz Sports Center exercise room. They will participate in 3 Wii balance board
games: a marble game, a skiing game, and a bubble game. Each subject will stand on a balance
board and participate in each of the 3 games for 10 minutes per game with 10 minutes rest in
between each of the games, a total of 30 minutes of balance training time per session.
Subjects will have a gait belt in place during the exercises, and will be supervised by a
physical therapist or research assistant. Either the Physical therapist or Research
Assistant will always be immediately next to the subjects during the training program. A
balance bar will also be next to the subject if needed for balance.
Weekly, subjects will be asked about any changes in medications or falls that they may have
experienced at home or in the community.
Visit 26
Subjects will seen for follow up assessments within 2 weeks of the final training session
and the following tests repeated:
1. Interval history (including falls), exam, Hoehn and Yahr Staging
2. Questionnaires:
1. Activities-Specific Balance Scale
2. PDQ-8
3. Geriatric Depression Scale.
3. Berg Balance Scale
4. Dynamic Gait Index
5. United Parkinson Disease Rating Scale, subscales
6. Sharpened Romberg
7. Wii Balance Board Testing
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 |